Denmark· DK-28104308008
Sebivo
A telbivudine product containing telbivudin, registered in Denmark by Novartis Europharm Limited. The same ATC class is registered in 5 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Telbivudine is registered in 5 of 19 countries.
Countries holding a registration under ATC J05AF11 (telbivudine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 3 of them publish a price we can compare per daily dose
Telbivudine · ATC J05AF11
5 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of telbivudine costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Telbivudine · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$19.99
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Telbivudin
- Manufacturer
- Novartis Europharm Limited
- Country
- Denmark (DK)
- ATC code
- J05AF11
- ATC class
- Telbivudine
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 9, 2026
Packs & prices · 1
- dk_varenummer28104308008
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
130 interactions on record for telbivudine.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Telbivudine · interactions on record
130 records
- 6 severe
- 124 moderate
Most severe, free to view
- Interferon alfa-2aL03AB04severe
- Interferon alfa-2bL03AB05severe
- Interferon alfa-n1L03AB06severe
- Interferon alfacon-1L03AB09severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Telbivudine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2d527906-77b5-4ef1-99d6-adcd4f072b16 GET /v1/drugs/2d527906-77b5-4ef1-99d6-adcd4f072b16?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "oral opløsning",
"source": "dkma",
"strength": "20 mg/ml",
"auth_role": "MOD",
"dk_drugid": "28104308008",
"substance": "Telbivudin",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "39833"
}See everything about telbivudine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.